dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc
Published 4 years ago • 319 plays • Length 0:39Download video MP4
Download video MP3
Similar videos
-
0:43
dr. eng on the fda approval of nivolumab plus ipilimumab in crc
-
4:22
dr awad on the fda approval of perioperative nivolumab for resectable nsclc
-
0:58
dr awad on the fda approval of perioperative nivolumab for resectable nsclc #lungcancer #fda
-
1:33
dr. borghaei on the fda approval of nivolumab in small cell lung cancer
-
1:34
fda approval of frontline nivolumab/ipilimumab combo in rcc
-
0:46
fda approval of second-dosing schedule of nivolumab
-
1:11
dr. lopes on the rationale to stop immunotherapy after 2 years in lung cancer
-
0:52
dr. mckay on fda approval of nivolumab/ipilimumab in frontline rcc
-
1:03
dr. herbst on combination of nivolumab and ipilimumab in patients with nsclc
-
0:57
dr. patel on the fda approval of durvalumab in nsclc
-
0:37
dr. petrylak on fda approval of nivolumab in bladder cancer
-
0:59
dr. weber on the fda approval for fixed-dose of nivolumab
-
1:03
sangeetha palakurthi on fda approval of atezolizumab in nsclc
-
1:08
dr. horn on the fda approval of atezolizumab plus bevacizumab and chemotherapy in nsclc
-
6:13
checkmate-227: testing ipilimumab/nivolumab in nsclc
-
0:59
mary j. fidler, md, provides opinion on the role of nivolumab ipilimumab in the treatment of nsclc
-
1:01
dr. renato martins on the unprecedented effects of nivolumab and ipilimumab
-
0:35
dr. farago on the fda approval of pembrolizumab for lower pd-1 cutoff nsclc
-
2:35
dr. west on fda approval of brigatinib in alk nsclc